Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)

Nephrology Dialysis Transplantation

Volumn 13, Issue 3, 1998, Pages 564-569

  Schmieder, Roland E ^a   Schlaich, Markus P ^a   Klingbeil, Arnfried U ^a   Martus, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DATABASES, FACTUAL; DIURETICS; DOUBLE-BLIND METHOD; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED;

EID: 0031908811     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.3.564     Document Type: Article

References (47)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566
2. Kannel WB. Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens 1991; 9 [Suppl]: S3-S9
3. Aronow WS, Ahn C, Kronzon I, Königsberg M. Congestive heart failure, coronary events, and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol 1991; 67: 295-299
4. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol 1988; 12: 994-1004
5. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med 1991; 114: 345-352
6. Silberberg JS, Barre P, Prichard S, Sniderman AD. Left ventricular hypertrophy: an independent determinant of survival in endstage renal failure. Kidney Int 1989; 36: 286-290
7. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in the uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031
8. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Int Med 1992; 117: 831-836
9. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990; 65: 441-445
10. MacMahon SW, McDonald GJ, Bernstein L, et al. Comparison of weight reduction with metoprolol and treatment of hypertension in young overweight patients. Lancet 1986; I: 1233-1236
11. MacMahon SW, Wilcken DEL, McDonald GJ. The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986; 314: 334-339
12. Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH Jr, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995; 91: 698-706
13. Jul AM, Karanko HM. Effects on left ventricular hypertrophy of long-term non-pharmacological treatment with sodium restriction in mild to moderate essential hypertension. Circulation 1994; 89: 1023-1031
14. Jennings G, Dart A, Meredith I, Korner P, Laufer E, Dewar E. Effects of exercise and other non-pharmacologic measures on blood pressure and cardiac hypertrophy. J Cardiovasc Pharmacol 1991; 17 [Suppl 2]: S70-S74
15. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens 1992: 5: 95-110
16. Cruickshank J, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy of different types of antihypertensive therapy. J Hum Hypertens 1992; 6: 85-90
17. Eagle KA, Blank DJ, Agniar E, Firth LM. Economic impact of regression of left ventricular hypertrophy by antihypertensive drugs. J Hum Hypertens 1993; 7: 341-351
18. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996; 275: 1507-1513
19. Sacks HS, Berrier J, Reitman D, Ancona-Berc VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316: 450-455
20. Thomas M. Regression of left ventricular hypertrophy [letter]. JAMA 1996; 276: 526
21. Fagard R. Reversal of left ventricular hypertrophy [letter]. JAMA 1996; 276: 1636-1637
22. Keleman MH, Effron MB, Valenti SA, Stewart KJ. Exercise training combined with antihypertensive drug therapy. Effects on lipids, blood pressure, and left ventricular mass. JAMA 1990; 263: 2766-2771
23. Gosse P, Roudaut R, Dallocchio M. Effets du verapamil et de la nifedipine sur la pression arterielle au repos et a l'effort et la masse ventriculaire gauche. Arch Mal Coeur 1992; 85: 1249-1252
24. Galderisi M, Celentano A, Garofalo M, Tammaro P, Oliviero M, Petrocelli A, De Divitis O. Reduction of left ventricular mass by short term antihypertensive treatment with isradipine: a double-blind comparison with enalapril. Int J Clin Pharmacol Ther 1994; 32: 312-316
25. Wambach G, Grimm U, Jacob R. Influence of the cardioselective betablockers celiprolol and atenolol on 24-h-blood pressure and left ventricular hypertrophy. Nieren- Hochdruckkr 1994; 23: 167-169
26. Schobel HP, Langenfeld M, Gatzka CD, Weihprecht H, Schmieder RE. Treatment and post-treatment effects of alpha-versus beta-receptorblockers on left ventricular structure and function in essential hypertension. Am Heart J 1996; 132: 1004-1009
27. Chen CH, Ting CH, Lin SJ, Hsu TL, Yin FCP, Siu CO, Chou P, Wang SP, Chang MS. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension 1995; 25: 1034-1041
28. Dey HM, Soufer R, Hoffer P, Wackers FJT, Black HR. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension. Am J Hypertens 1996; 9: 598-606
29. Fogari R, Zoppi A, Mugellini A, Tettamanti F, Lusardi P, Corradi L. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension. Eur Heart J 1995; 16: 1120-1125
30. Trenkwalder P, Dobrindt R, Aulehner R, Lydtin H. Antihypertensive treatment with felodipine but not with a diuretic reduces episodes of myocardial ischemia in elderly patients with hypertension. Eur Heart J 1994; 15: 1673-1680
31. Kan Y, Hong Z, Ming S. Effects of nitrendipine and captopril on the quality of life in hypertensives with left ventricular hypertrophy. Bull Human Med Univ 1995; 20: 450-452
32. Kirpizidis HG, Papazachariou GS. Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: A double-blind study. Cardiovasc Drugs Ther 1995; 9: 141-143
33. Middlemost SJ, Tager R, Davis J, Sareli P. Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. Am J Cardiol 1994; 73: 1092-1097
34. Henderson RJ, Cranswick RW, Hunyor SN. Structural adaptation of the heart in borderline hypertensives in response to blood pressure lowering with captopril. J Hypertens 1994; 12: 65-72
35. Komsuoglu B, Göldeli Ö, Gacar N, Cetinarslan B, Komsuoglu SS, Kulan K. The effects of nitrendipine and verapamil on the index of left ventricular mass in elderly hypertensives with left ventricular hypertrophy. Tr J Med Sci 1994; 21: 97-102
36. Gonzalez-Juanatey JR, Garcia-Acuna JM, Calvo Gomez C, Amaro Cendon A, Fernandez-Lopez JA, Gil de la Pena M. Effect of verapamil and nitrendipine on left ventricular mass and function (systolic and diastolic) in arterial hypertension. Rev Esp Cardiol 1994; 47: 375-383
37. Nagano M, Higaki J, Mikami H, Nakamura M, Higashimori K, Katahira K, Tabuchi Y, Moriguchi A, et al. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J Hypertens 1991; 9: 595-599
38. Schmieder RE, Langenfeld MRW, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94: 1304-1309
39. Schlaich MP, Schobel H, Langenfeld MRW, Hilgers K, Schmieder RE. Inadequate suppression of angiotensin II modulates left ventricular hypertrophy in humans. Am J Hypertens 1997; 10: 28A (Abstract)
40. Lubic SP, Giacomini KM, Giacomini JC. Myocardial hypertrophy in cell culture is associated with increased number of calcium channels. Circulation 1990; 82 [Suppl III]: S142
41. Inoue I, Matsuura H, Shingu T, Kawagoe T, et al. Role of intracellular cation abnormalities in development of left ventricular hypertrophy. J Cardiovasc Pharmacol 1991; 17 [Suppl 2]: S007-S109
42. Rockstroh JK, Vogt-Ladner G, Neumayer HH, Hauser I, Schmieder RE. Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation. Nephrol Dial Transpl 1997; 12: 1441-1447
43. Koren MJ, Ulin R, Laragh JH, Devereux RB. Reduction of left ventricular mass during treatment of essential hypertension is associated with improved prognosis. Am J Hypertens 1991; 4: 1A (Abstract)
44. Yurenev AP, Dyakonova HG, Novkov ID, et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Am J Hypertens 1992; 5: 5182-5189
45. Levy D, Salomon M, D'Agostino RB, Belanger M, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial change in subjects with electrocardiographic left ventricular hypertrophy. Circulation 1994; 90: 1786-1793
46. Muiesan ML, Salvetti M, Rizzoni D, et al. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1996; 13: 1091-1095
47. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Sacchi N, Benemio G, Porcellati C. Prognostic value of serial changes in left ventricular mass in essential hypertension. Am J Hypertens 1997; 10: 25A (Abstract)